|
Opioid and CB1 receptors involvement in central anti-nociceptive effect of vitamin C in the formalin-induced pain model in rats
|
Amir Erfanparast *    , Esmaeal Tamaddonfard , Sina Tamaddonfard , ,Yasin Esmaeilou , Raziyeh Daneshyar , Dorsa Raissian |
| Department of Physiology, Group of Basic Sciences, Faculty of Veterinary Medicine, Urmia Universiry, Urmia, Iran |
|
|
Abstract: (839 Views) |
Background and Aim: Although the analgesic effect of vitamin C was reported in several studies, its supra-spinal analgesia and the involved mechanisms have not been investigated yet. In this study, central effect of vitamin C in formalin-induced pain was investigated. Naloxone (an opioid receptor antagonist) and AM251 (a CB1 receptor antagonist) were used to clarify the possible mechanism of this vitamin.
Methods: In ketamine-xylazine anesthetized rats, one stainless-steel guide cannula was implanted into the fourth ventricle of the brain. The formalin test was induced by intra-plantar injection of formalin (50 mL, 2.5%), and the time spent licking and biting of the injected paw was recorded for 1 h.
Results: A marked biphasic (first phase: 0–5 min and second phase: 15–50 min) pain response was induced after formalin injection. Intra-fourth ventricle injection of vitamin C significantly (p < 0.05) decreased both phases of pain. Naloxone and AM251 had no effect on the pain intensity. However, the analgesic effect of vitamin C was inhibited by pretreatments with naloxone and AM251. All the above-mentioned treatments did not alter locomotor activity of the animals.
Conclusion: These results showed that vitamin C suppresses formalin-induced neurogenic and inflammatory pains in rats through central modulatory mechanisms. Opioid and cannabinoid receptors play a role in the analgesic effects of vitamin C.
|
|
| Keywords: Cannabinoid receptors, Formalin pain, Fourth ventricle, Vitamin C, Opioid receptor |
|
|
Full-Text [PDF 1003 kb]
(340 Downloads)
|
|
Type of Study: Original Research |
Subject:
Neuroscience
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
